Adam McNulty

Adam McNulty has extensive work experience in business development and transactions. Adam is currently the Vice President of Business Development at Blueprint Medicines, a position they have held since 2023. Prior to that, they worked as the Senior Director of Business Development at the same company from 2021 to 2023. Before joining Blueprint Medicines, Adam held various roles at companies such as Chiesi Group, AstraZeneca, Harvard University, and Interleukin Genetics, Inc., where they gained experience in business development and transactions. Adam has a strong background in the pharmaceutical and biotechnology industries and has demonstrated expertise in scientific partnering and alliances.

Adam McNulty completed their Bachelor's degree in Biology at Trinity College-Hartford from 1998 to 2002. Adam later pursued an MBA from the D'Amore-McKim School of Business at Northeastern University, completing it from 2003 to 2006.